Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) gapped up before the market opened on Tuesday. The stock had previously closed at $9.83, but opened at $10.5350. Aspen Pharmacare shares last traded at $10.5350, with a volume of 136 shares.
Aspen Pharmacare Trading Up 7.2%
The company has a quick ratio of 1.68, a current ratio of 2.54 and a debt-to-equity ratio of 0.12. The firm has a 50 day moving average of $9.63 and a 200 day moving average of $8.70.
Aspen Pharmacare Company Profile
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers. The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
See Also
- Five stocks we like better than Aspen Pharmacare
- Bonds Are Paying 5% Again, and the Repricing Has Reached Every Corner of the Market
- Archer Aviation’s FAA Certificate Is a Milestone, But It Isn’t the Final One
- Microsoft’s Neocloud Pullback Isn’t a Crack in AI Demand
- Fox’s $22 Billion Roku Acquisition Reshapes Its Streaming Business
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
